CP
WST icon

Castleview Partners’s West Pharmaceutical WST Stock Holding History

Castleview Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$316K Buy
+880
New +$291K 0.14% 154

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Castleview Partners's WST Position: Q2 2021 in Review

Castleview Partners opened a new position in West Pharmaceutical (WST) in Q2 2021: 880 shares worth $316K. The stake represents 0.14% of the portfolio and ranks #154 among its holdings.

640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • Castleview Partners held 880 shares of West Pharmaceutical worth $316K as of Q2 2021.
  • West Pharmaceutical was a new Castleview Partners position in Q2 2021.
  • West Pharmaceutical made up 0.14% of Castleview Partners's portfolio in Q2 2021, its #154 holding.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.